Results 261 to 270 of about 196,164 (338)

Efficacy of BTK inhibitor combined with rituximab and lenalidomide in newly diagnosed diffuse large B-cell lymphoma: a single-center, retrospective study. [PDF]

Ann Hematol
Lv Y, Zhu Y, Yang C, Zhang X, Zhang X, Wei J, Ye X, Xu G, Mao L, Mai W, Yang M, Qian J, Tong H, Jin J, Yu W.   +14 more
europepmc   +1 more source

Ethical and Regulatory Considerations in the Clinical Translation of Pluripotent Stem Cell‐Derived NK Cell Therapies

Cell Proliferation, EarlyView.
Advancements in the generation of human pluripotent stem cell‐derived natural killer (PSC‐NK) cells have attracted considerable attention within the biomedical research community, offering a promising off‐the‐shelf technique for universal immune therapy.
Qianwen Chen, Jianwei Lv, Xinwei Xie, Hanlin Zhu, Zhenyu Xiao, Yaojin Peng   +5 more
wiley   +1 more source

Rituximab-Induced Interstitial Lung Disease: A Possible Underestimated Complication-A Systematic Review. [PDF]

Cancers (Basel)
Zamfir AS, Marinca MV, Zamfir CL, Bordeianu G, Deac AL, Ciuntu BM, Pintilie CT, Ojog D, Brînză M, Cernomaz TA.   +9 more
europepmc   +1 more source

Adjuvant therapy of severe and/or refractory bullous pemphigoid with immunoadsorption – A prospective monocenter pilot study

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and Objectives Bullous pemphigoid (BP) is the most common autoimmune blistering disease in the Western world. While remission is achieved in the majority of BP patients by long‐term use of corticosteroids with or without immunomodulants/immunosuppressants, national and international guidelines recommend adjuvant immunoadsorption (IA)
Maike M. Holtsche, Nina van Beek, Christoph M. Hammers, Artem Vorobyev, Michael Kasperkiewicz, Nina Schumacher, Philip Muck, Enno Schmidt   +7 more
wiley   +1 more source

Induction chemotherapy with methotrexate, nimustine, and procarbazine for primary CNS lymphoma in the elderly: a retrospective evaluation of safety and efficacy. [PDF]

J Neurooncol
Umezawa Y, Yamamoto M, Tanaka K, Yoshifuji K, Akiyama H, Nogami A, Nagao T, Mori T.   +7 more
europepmc   +1 more source

Cutaneous non‐tuberculous mycobacterial infections: A retrospective study of 94 cases from Germany

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background Cutaneous non‐tuberculous mycobacterial infections (NTM) remain a diagnostic and therapeutic challenge. The aim of this study was to characterize cutaneous NTM infections in Germany over a 24‐year‐period. Patients and Methods 73 patients with cutaneous NTM infections diagnosed at 17 different German University Hospitals from 2000 ...
Luisa Bopp, Nicolai Deresz, Henning Klapproth, Isabelle Suárez, Jonathan Jantsch, Mario Fabri, Esther von Stebut   +6 more
wiley   +1 more source

Exploring rituximab for the treatment of refractory myasthenia gravis: a single-centre experience. [PDF]

BMJ Neurol Open
Roddate M, Žukova V, Grosmane A, Ķauķe G, Glāzere I, Punga AR, Ķēniņa V.   +6 more
europepmc   +1 more source

Efficacy of Rituximab Combined with Glucocorticoid for Nephrotic Syndrome and the Impact on Renal Function, Coagulation Function, and Inflammatory Response

Si Shi, Jie Zeng, Yang Liu, Bingquan Li
openalex   +2 more sources

Immune‐related toxicity profile after haematopoietic stem cell transplantation in patients with B‐ALL given combination immunotherapy with rituximab, inotuzumab and blinatumomab

British Journal of Haematology, EarlyView.
Olayinka Okeleji, David McCall, Branko Cuglievan, Amber Gibson, Demetrios Petropoulos, Priti Tewari, Jeremy Connors, Irtiza N. Sheikh   +7 more
wiley   +1 more source

Effectiveness of Rituximab, Belimumab, and Thrombopoietin Receptor Agonists in Refractory Immune Thrombocytopenia Associated With Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Ohta R, Ryu Y, Ichinose K.
europepmc   +1 more source